Mannan-Binding Lectin via Interaction With Cell Surface Calreticulin Promotes Senescence of Activated Hepatic Stellate Cells to Limit Liver Fibrosis Progression. [PDF]
Luo J+10 more
europepmc +1 more source
Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk [PDF]
Saedís Saevarsdóttir+6 more
openalex +1 more source
Mannan-Binding Lectin Deficiency Limits Inflammation-induced Myeloid-Derived Suppressor Cells Expansion via Modulating Tumor Necrosis Factor Alpha-triggered Apoptosis. [PDF]
Dong L+14 more
europepmc +1 more source
Levels, Complement Activity and Polymorphisms of Mannan‐Binding Lectin in Patients of Bronchial Asthma with Allergic Rhinitis [PDF]
S. Sukhija+5 more
openalex +1 more source
Mannose/mannan-binding lectin (MBL) is a serum lectin synthesized (as a ~32 kDa peptide) by the liver and is one of the key molecules of the innate immune system. Each peptide has an N (amino)-terminal cysteine-rich region, a middle stretch of a collagen-like sequence, and a carbohydrate recognition domain (CRD) in the C (carboxy)-terminus.
Dinasarapu, Ashok Reddy+3 more
openaire +1 more source
Mannose-binding lectin (MBL) binds to SARS-CoV-2, inhibits infection of susceptible cells, and activates the complement system via the lectin pathway. In this study, we investigated the association of MBL2 polymorphisms with the risk of hospitalization ...
Lorena Viana de Andrade+7 more
doaj
Preoperative Mannan‐Binding Lectin Pathway and Prognosis in Colorectal Cancer [PDF]
Henriette Ytting+4 more
openalex +1 more source
Functional Characterization of Complement Proteases C1s/Mannan-binding Lectin-associated Serine Protease-2 (MASP-2) Chimeras Reveals the Higher C4 Recognition Efficacy of the MASP-2 Complement Control Protein Modules [PDF]
Véronique Rossi+4 more
openalex +1 more source
Mannan-binding lectin and procalcitonin measurement for prediction of postoperative infection. [PDF]
Michael Siassi+6 more
openalex +1 more source
Serum opsonization of yeast (Saccharomyces) was investigated in 51 patients whose ages were between six and 48 months (median 15 months) with acute purulent otitis media and in an age-matched control group (median 13 months).
I Tezcan+7 more
doaj